Widespread naloxone access is a key policy response to the opioid crisis. Naloxone availability is typically estimated from pharmacy sales, which exclude naloxone provided by community organizations, hospitals, and clinics, or sold over-the-counter. Research objective: To estimate naloxone knowledge, carrying, purchase, and use among US adults.

Naloxone prescriptions to adolescents increased dramatically over the past few years but still are too low given rising rates of opioid overdoses, according to a new study.

Opioids kill more people than any other class of drug. Naloxone is an opioid antagonist which can be distributed in kits for peer administration. Researchers assessed the feasibility of implementing a Take-home Naloxone (THN) intervention in emergency settings, as part of designing a definitive randomised controlled trial (RCT).

Post-overdose outreach, often by public health and public safety partnerships, seeks to connect overdose survivors with naloxone, overdose education, and treatment to reduce the high risk of a subsequent fatal overdose, but outreach strategy and methods vary widely by municipality.

This release by Public Health Scotland presents information on the number of take-home naloxone kits issued by the National Naloxone Programme in Scotland. Figures are presented separately for kits issued from community outlets, kits issued in prisons at the point of prisoner release, kits dispensed via community prescription, and kits issued by Scottish Ambulance Service.

Take home naloxone (THN) programs have been rapidly upscaled in response to increasing opioid-related mortality. One often cited concern is that naloxone provision could be associated with increased opioid use, due to the availability of naloxone to reverse opioid overdose. Researchers conducted a systematic review to determine whether THN provision is associated with changes in substance use by participants enrolled in THN programs.